← Back to all trials
Not Yet Recruiting
NCT05654233
The Study of Reducing Adverse Effects After Radiofrequency Ablation Combined With Sclerotherapy
Conditions: Vascular Diseases, Peripheral, Venous Insufficiency of Leg, Varicose Veins of Lower Limb
Sex: All
Ages: 18 Years – 80 Years
Phase: NA
Enrollment: 120
Sponsor: Chengdu University of Traditional Chinese Medicine
Location: China
Summary
The purpose of this study is to evaluate whether adding sulodexide to the patients with varicose veins who received radiofrequency ablation combined with sclerotherapy can reduce or improve the impact of adverse events。
Eligibility Criteria
Inclusion Criteria:Age >18 years and <80 years, and able to understand the requirements of the study and provide informed consent and accept the exams and follow-up.C2 - C5 varicose veins / CVI Symptomatic primary GSV, SSV, or AASV incompetence, with reflux >0.5 seconds on color duplex, eligible for patients undergoing radiofrequency ablation plus sclerotherapyBMI<35The skin color is within the normal range, and no obvious skin color unevenness or skin diseases affect the observed indicators.Exclusion Criteria:Acute superficial or deep vein thrombosisHistory of asthma and strokeThere are skin diseases, scars, infections, and other conditions in the surgical area that affect the observation indicatorsPregnancySerious damage to liver and kidney functionSevere obesity (BMI>35) and severe edema of the lower extremitiesOthers are not eligible for intravenous radiofrequency ablation combined with sclerotherapy
Source: ClinicalTrials.gov (NCT05654233). StuddyBuddy aggregates publicly available trial information.
